← Eichor
Study identifier: NCT05505643 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Cryoablation vs Lumpectomy in T1 Breast Cancers

Condition: Breast Cancer · Breast Neoplasm  ·  Sponsor: Washington University School of Medicine

PhaseNA
Planned participants120
Who can joinFemale, 50 Years to no upper limit
Healthy volunteersNo

About this study

This trial studies the efficacy and safety of cryoablation in patients with low risk, early stage breast cancer. Cryoablation is a method of killing a tumor by freezing it. The standard approach for patients with this kind of cancer is a lumpectomy. This study will review the safety of the cryoablation procedure initially, followed by comparing cryoablation to lumpectomy in order to see if the cryoablation results in better disease control, complication rates, and quality of life.

This description comes directly from the study's public registry record.

Talk to the study team

Heather Garrett, M.D.  ·  636-916-9662  ·  hvgarrett@wustl.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Washington University School of MedicineSt Louis, Missouri, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05505643